Sfoglia per Autore
Clinical severity instruments
2005-01-01 Zangrilli, A; Talamonti, M; Saraceno, R; Chimenti, S
Erysipeloid cutaneous metastasis from bladder carcinoma
2007-01-01 Zangrilli, A; Saraceno, R; Sarmati, L; Orlandi, A; Bianchi, L; Chimenti, S
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics
2007-01-01 Papoutsaki, M; Chimenti, Ms; Costanzo, A; Talamonti, M; Zangrilli, A; Giunta, A; Bianchi, L; Chimenti, S
Adalimumab for moderate to severe psoriasis: an open-label, retrospective 3-year study
2008-01-01 Papoutsaki, M; Chimenti, Ms; Talamonti, M; Zangrilli, A; Teoli, M; Kroegler, B; Perricone, R; Chimenti, S
Long-term efficacy of adalimumab in generalized pustular psoriasis
2008-01-01 Zangrilli, A; Papoutsaki, M; Talamonti, M; Chimenti, S
Radiologically significant joint improvement in a patient affected by psoriatic arthritis treated with adalimumab
2009-01-01 Chimenti, Ms; Papoutsaki, M; Teoli, M; Zangrilli, A; Perricone, R; Chimenti, S
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis
2013-01-01 Saraceno, R; Pietroleonardo, L; Mazzotta, A; Zangrilli, A; Bianchi, L; Chimenti, S
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study
2013-01-01 Esposito, M; Giunta, A; Mazzotta, A; Zangrilli, A; Babino, G; Bavetta, M; Perricone, R; Chimenti, S; Chimenti, Ms
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis
2013-01-01 Saraceno, R; Bavetta, M; Zangrilli, A; Chiricozzi, A; Potenza, C; Chimenti, S; Chimenti, Ms
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations
2014-11-01 Marinari, B; Botti, E; Bavetta, M; Spallone, G; Zangrilli, A; Talamonti, M; Richetta, A; Chimenti, S; Costanzo, A
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk
2015-01-01 Chiricozzi, A; Bianchi, L; Zangrilli, A; Bavetta, M; Giunta, A; Chimenti, S; Saraceno, R
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study.
2017-01-01 Chiricozzi, A; Zangrilli, A; Bavetta, M; Bianchi, L; Chimenti, S; Saraceno, R
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study.
2017-01-01 Talamonti, M; Galluzzo, M; Zangrilli, A; Papoutsaki, M; Egan, C; Bavetta, M; Tambone, S; Fargnoli, M; Bianchi, L
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey
2018-01-01 Potenza, M; Peris, K; Berardesca, E; Bianchi, L; Richetta, A; Bernardini, N; De Simone, C; Teoli, M; Zangrilli, A; D’Epiro, S; Orsini, D; Narcisi, A; Chimenti, S; Costanzo, A
Long-term treatment of psoriatic patients with adalimumab reduces disease severity and maintains a favorable lipid pattern and a low Atherogenic Index.
2018-01-01 Zangrilli, A; Bavetta, M; Scaramella, M; Bianchi, L
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey
2018-01-01 Potenza, Mc; Peris, K; Berardesca, E; Bianchi, L; Richetta, A; Bernardini, N; De Simone, C; Teoli, M; Zangrilli, A; D'Epiro, S; Orsini, D; Narcisi, A; Chimenti, S; Costanzo, A
Paradoxical case effects of psoriasis following adalimumab therapy: A case series
2018-01-01 Zangrilli, A; Bavetta, M; Mazzilli, S; Garofalo, V; Bianchi, L
Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice
2019-01-01 Esposito, M; Prignano, F; Rongioletti, F; Hansel, K; Bianchi, L; Pescitelli, L; Lazzeri, L; Ricceri, F; Mugheddu, C; Bavetta, M; Zangrilli, A; Bianchi, L; Bini, V; Stingeni, L
One drug and two diseases: A case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast
2019-01-01 Lanna, C; Mazzilli, S; Zangrilli, A; Bianchi, L; Campione, E
Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation
2019-10-03 Lernia, Vd; Bianchi, L; Guerriero, C; Stingeni, L; Gisondi, P; Filoni, A; Guarneri, C; Belloni Fortina, A; Lasagni, C; Simonetti, O; Neri, I; Zangrilli, A; Moretta, G; Hansel, K; Casanova, Dm; Girolomoni, G; Cannavò, Sp; Bonamonte, D
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
1-gen-2005 | Clinical severity instruments | Zangrilli, A; Talamonti, M; Saraceno, R; Chimenti, S | Contributo in libro | |
1-gen-2007 | Erysipeloid cutaneous metastasis from bladder carcinoma | Zangrilli, A; Saraceno, R; Sarmati, L; Orlandi, A; Bianchi, L; Chimenti, S | Articolo su rivista | |
1-gen-2007 | Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics | Papoutsaki, M; Chimenti, Ms; Costanzo, A; Talamonti, M; Zangrilli, A; Giunta, A; Bianchi, L; Chimenti, S | Articolo su rivista | |
1-gen-2008 | Adalimumab for moderate to severe psoriasis: an open-label, retrospective 3-year study | Papoutsaki, M; Chimenti, Ms; Talamonti, M; Zangrilli, A; Teoli, M; Kroegler, B; Perricone, R; Chimenti, S | Intervento a convegno | |
1-gen-2008 | Long-term efficacy of adalimumab in generalized pustular psoriasis | Zangrilli, A; Papoutsaki, M; Talamonti, M; Chimenti, S | Articolo su rivista | |
1-gen-2009 | Radiologically significant joint improvement in a patient affected by psoriatic arthritis treated with adalimumab | Chimenti, Ms; Papoutsaki, M; Teoli, M; Zangrilli, A; Perricone, R; Chimenti, S | Articolo su rivista | |
1-gen-2013 | TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis | Saraceno, R; Pietroleonardo, L; Mazzotta, A; Zangrilli, A; Bianchi, L; Chimenti, S | Articolo su rivista | |
1-gen-2013 | Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study | Esposito, M; Giunta, A; Mazzotta, A; Zangrilli, A; Babino, G; Bavetta, M; Perricone, R; Chimenti, S; Chimenti, Ms | Articolo su rivista | |
1-gen-2013 | Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis | Saraceno, R; Bavetta, M; Zangrilli, A; Chiricozzi, A; Potenza, C; Chimenti, S; Chimenti, Ms | Articolo su rivista | |
1-nov-2014 | Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations | Marinari, B; Botti, E; Bavetta, M; Spallone, G; Zangrilli, A; Talamonti, M; Richetta, A; Chimenti, S; Costanzo, A | Articolo su rivista | |
1-gen-2015 | Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk | Chiricozzi, A; Bianchi, L; Zangrilli, A; Bavetta, M; Giunta, A; Chimenti, S; Saraceno, R | Articolo su rivista | |
1-gen-2017 | Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. | Chiricozzi, A; Zangrilli, A; Bavetta, M; Bianchi, L; Chimenti, S; Saraceno, R | Articolo su rivista | |
1-gen-2017 | HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study. | Talamonti, M; Galluzzo, M; Zangrilli, A; Papoutsaki, M; Egan, C; Bavetta, M; Tambone, S; Fargnoli, M; Bianchi, L | Articolo su rivista | |
1-gen-2018 | Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey | Potenza, M; Peris, K; Berardesca, E; Bianchi, L; Richetta, A; Bernardini, N; De Simone, C; Teoli, M; Zangrilli, A; D’Epiro, S; Orsini, D; Narcisi, A; Chimenti, S; Costanzo, A | Articolo su rivista | |
1-gen-2018 | Long-term treatment of psoriatic patients with adalimumab reduces disease severity and maintains a favorable lipid pattern and a low Atherogenic Index. | Zangrilli, A; Bavetta, M; Scaramella, M; Bianchi, L | Articolo su rivista | |
1-gen-2018 | Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey | Potenza, Mc; Peris, K; Berardesca, E; Bianchi, L; Richetta, A; Bernardini, N; De Simone, C; Teoli, M; Zangrilli, A; D'Epiro, S; Orsini, D; Narcisi, A; Chimenti, S; Costanzo, A | Articolo su rivista | |
1-gen-2018 | Paradoxical case effects of psoriasis following adalimumab therapy: A case series | Zangrilli, A; Bavetta, M; Mazzilli, S; Garofalo, V; Bianchi, L | Articolo su rivista | |
1-gen-2019 | Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice | Esposito, M; Prignano, F; Rongioletti, F; Hansel, K; Bianchi, L; Pescitelli, L; Lazzeri, L; Ricceri, F; Mugheddu, C; Bavetta, M; Zangrilli, A; Bianchi, L; Bini, V; Stingeni, L | Articolo su rivista | |
1-gen-2019 | One drug and two diseases: A case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast | Lanna, C; Mazzilli, S; Zangrilli, A; Bianchi, L; Campione, E | Articolo su rivista | |
3-ott-2019 | Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation | Lernia, Vd; Bianchi, L; Guerriero, C; Stingeni, L; Gisondi, P; Filoni, A; Guarneri, C; Belloni Fortina, A; Lasagni, C; Simonetti, O; Neri, I; Zangrilli, A; Moretta, G; Hansel, K; Casanova, Dm; Girolomoni, G; Cannavò, Sp; Bonamonte, D | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile